Skip to main content
SpringerLink
Log in

Eicosanoids and Diabetic Hypertension

  • Conference paper
Diabetes and Hypertension

  • 106 Accesses

Abstract

Hypertension is more common in juvenile onset diabetes than in the normal population and is considered to be a major risk factor in this group of patients (Christlieb et al. 1981). More than 2.5 million Americans suffer from diabetes associated with hypertension (Working Group on Hypertension in Diabetes 1987). The development of the vascular complications of diabetes, namely diabetic macro- and microangiopathy and the prothrombotic stage, eventually combined with diabetic hypertension, might be facilitated by a more general disturbance in the defence mechanisms of the body, being related to insulin deficiency. This involves alterations in eicosanoid production that are not only important for control of insulin secretion (Rösen and Hohlfeld 1985; Robertson 1986) but also for the vascular and thrombotic complications of the disease. This paper reviews the present evidence for a contribution of disturbed eicosanoid production to the vascular complications in diabetes mellitus with particular emphasis on hypertension.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aanderud S, Krane H, Nordoy A (1985) Influence of glucose, insulin and sera from diabetic patients on the prostacyclin synthesis in vitro in cultured human endothelial cells. Diabetologia 28: 641–644

    Article  PubMed  CAS  Google Scholar 

  • Arisaka M, Arisaka O, Fukuda Y, Yamashiro Y (1986) Prostaglandin metabolism in children with diabetes mellitus: I. Plasma prostaglandin E2, F2α, TXB2, and serum fatty acid levels. J Pediatr Gastroenterol Nutr 5: 878–882

    Article  PubMed  CAS  Google Scholar 

  • Axelrod L, Shulman Gl, Blackshear PJ, Borastein M, Roussell AM, Aoki TT (1986) Plasma level of 13,14-düiydro-15-keto-PGE2 in patients with diabetic ketoacidosis and in normal fasting subjects. Diabetes 35: 1004–1010

    Article  PubMed  CAS  Google Scholar 

  • Bresser H-J, Rösen P, Schrör K (1987) Insulin treatment normalizes the arachidonie acid induced prostacyclin release from the platelet-perfused diabetic rat heart. Evidence for major changes in 15- HETE production. In: Sinzinger H, Sehrör K (eds) Prostaglandins in Clinical Research Alan R. Liss, Inc. New York, p 143–148

    Google Scholar 

  • Broderick R, Tulenko T (1983) Cholesterol increases noradrenalin ( NE) sensitivity in perfused rabbit femoral arteries. Fed Proc 42: 1387

    Google Scholar 

  • Brunner D, Klinger J, Weisbort J, Tuval M, Nakash J, Rosenberg CH, Nissim S (1984) Thromboxane, prostacyclin, beta-thromboglobin, and diabetes mellitus. Clin Ther 6: 636–642

    PubMed  CAS  Google Scholar 

  • Christlieb AR, Warram JH, Kodewski AS, Busick EJ, Guanda OP, Asmal AC, Soeldner JS (1981) Hypertension: the major risk factor in juvenile onset insulin dependent diabetics. Diabetes 30 [Suppl 2]: 90–96

    PubMed  CAS  Google Scholar 

  • Collier A, Tymkewycz P, Armstrong R, Young RJ, Jones RL, Clarke BF (1986) Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy. Diabetologia 29: 471–474

    Article  PubMed  CAS  Google Scholar 

  • Colwell JA, Winocour PD, Halushka PV (1983) Do platelets have anything to do with diabetic microvascular disease? Diabetes 32 [Suppl 2]: 14–19

    PubMed  Google Scholar 

  • Davis TM, Bown E, Turner RC (1985) Platelet sensitivity in vitro to adenosine-5-diphosphate and prostacyclin and diabetic retinopathy. Diabetologia 28: 274–276

    Article  PubMed  CAS  Google Scholar 

  • Esmatjes E, Fernandez MR, Halperin I, Camps J, Gaya J, Arroyo V, Rivera F, Figuerola D (1985) Renal hemodynamic abnormalities in patients with short term insulin-dependent diabetes mellitus: role of renal prostaglandins. J. Clin Endocrinol Metab 60: 1231–1236

    Article  PubMed  CAS  Google Scholar 

  • Feigl W, Sinzinger H, Santler R, Oppolzer R, Silberbauer K (1986) In vitro Prostaglandin I2-Synthese normaler und pathologisch veränderter menschlicher Beinvenen. Vasa 15: 47–51

    PubMed  CAS  Google Scholar 

  • Funakawa S, Okahara T, Imanishi M, Komori T, Yamamoto K, Tochino Y (1983) Renin-angiotensin system and prostacyclin biosynthesis in streptozotocin diabetic rats. Eur J Pharmacol 94: 27–33

    Article  PubMed  CAS  Google Scholar 

  • Guicheney P, Baudoin-Legros M, Meyer P (1987) Study of in vivo platelet activation in uncomplicated essential hypertension. Thromb Res 40: 615–621

    CAS  Google Scholar 

  • Halushka PV, Rogers RC, Loadhold CB, Colwell JA (1981) Increased platelet-thromboxane synthesis in diabetes mellitus. J Lab Clin Med 97: 87–96

    PubMed  CAS  Google Scholar 

  • Harrison HE, Reece AH, Johnson M (1978) Decreased vascular prostacyclin in experimental diabetes. Life Sci 23: 351–356

    Article  PubMed  CAS  Google Scholar 

  • Harrison HE, Reece AH, Johnson M (1980) Effect of insulin treatment on prostacyclin in experimental diabetes. Diabetologia 18: 65–68

    Article  PubMed  CAS  Google Scholar 

  • Hayashi M, Senba S, Saito I, Kitajima W, Saruta T (1983) Changes in blood pressure, urinary kallikrein, and urinary prostaglandin E2 in rats with streptozotocin-induced diabetes. Naunyn- Schmiedebergs Arch Pharmacol 322: 290–294

    Article  PubMed  CAS  Google Scholar 

  • Inoguchi T, Umeda F, Watanabe J, Ibayashi H (1986) Reduced serum-stimulatory activity on prostacyclin production by cultured aortic endothelial cells in diabetes mellitus. Haemostasis 16: 447–452

    PubMed  CAS  Google Scholar 

  • Johnson M, Harrison HE, Raftery AT, Eldor JB (1979) Vascular prostacyclin may be reduced in diabetes in man. Lancet i: 325–326

    Google Scholar 

  • Jones DB, Carter RD, Haitas B, Mann JI (1983) Low phospholipid arachidonic acid values in diabetic platelets. Br Med J 286: 173

    Article  CAS  Google Scholar 

  • Karpen CW, Cataland S, O’Dorisio CM, Panganamala RV (1985) Production of 12-hydroxyeicosatetraenoic acid and vitamin E status in platelets from type I human diabetic subjects. Diabetes 34: 526–531

    CAS  Google Scholar 

  • Katayama S, Lee JB (1985) Hypertension in experimental diabetes mellitus. Renin-prostaglandin interaction. Hypertension 7: 554–561

    PubMed  CAS  Google Scholar 

  • Katayama S, Inaba M, Maruno Y, Omoto A, Kawazu S, Ishii J (1987) Increased thromboxane B2 excretion in diabetes mellitus. J Lab Clin Med 109: 711–717

    PubMed  CAS  Google Scholar 

  • Komori T, Fujii S, Nogi O, Ohashi M, Sasakawa O, Yamamoto K (1985) Prostacyclin production reduced in diabetics with vascular complications. Jpn J Med 24: 231–235

    Article  PubMed  CAS  Google Scholar 

  • Kubisz P, Arabi A, Holan J, Cronberg S (1984) Investigations on platelet function in diabetes mellitus. Haemostasis 14: 347 - 353

    PubMed  CAS  Google Scholar 

  • Lagarde M, Burtin M, Berciaud P, Blanc M, Velardo B, Dechavanne M (1980) Increase of thromboxane A2 formation and of its plasmatic half life in diabetes mellitus. Thromb Res 19: 823–830

    Article  PubMed  CAS  Google Scholar 

  • Lucas FV, Skrinska VA, Chisolm GM, Hesse BL (1986) Stability of prostacyclin in human and rabbit whole blood and plasma. Thromb Res 43: 379–387

    Article  PubMed  CAS  Google Scholar 

  • MacLeod KM, McNeill JH (1985) The influence of chronic experimental diabetes on contractile response of rat isolated blood vessels. Can J Physiol Pharmacol 63: 52–57

    Article  PubMed  CAS  Google Scholar 

  • McNamara DB, Donath GR, Kadowitz PJ, Hyman AL, Rush DS, Kerstein MD (1986) Prostacyclin synthetase activity in human diabetic and nondiabetic vascular tissue. J Vase Surg 4: 63–67

    CAS  Google Scholar 

  • McRae JR, Day RP, Metz SA, Halter JB, Ensinck JW, Robertson RP (1985) Prostaglandin E2 metabolicte levels during diabetic ketoacidosis. Diabetes 34: 761–766

    Article  PubMed  CAS  Google Scholar 

  • Metz SA, Rice MG, Robertson RP (1979) Application and limitations of measurements of 15-keto- 13,14-dihydro-prostaglandinE2 in human blood by radioimmunoassay. Prostaglandins 17: 839–861

    Article  PubMed  CAS  Google Scholar 

  • Mourits:Andersen T, Jensen R, Dyerberg J (1986) Plasma prostaglandins: 6-keto-PGFla, TXB2 and PGE2 in juvenile-onset diabetes determined by high-pressure liquid chromatography and radioimmunoassay. Prostaglandins Leukotrienes Med 22: 335–348

    Google Scholar 

  • Müller SM, Müller TM, Ertel PJ (1982) Sympathetic and vascular dysfunction in early experimental juvenile diabetes mellitus. Am J Physiol 243: H139–H144

    Google Scholar 

  • O’Malley BC, Timperly WR, Ward JD, Porter NR (1975) Platelet abnormalities in diabetic peripheral neuropathy. Lancet ii: 1274–1276

    Google Scholar 

  • Pfaffman MA, Ball CR, Darby A, Hilman R (1982) Insulin reversal of diabetes-induced inhibition of vascular contractility in the rat. Am J Physiol 242: H490–H495

    PubMed  CAS  Google Scholar 

  • Pottathil R, Huang SW, Chandrabose KA (1985) Essential fatty acids in diabetes and systemic lupuserythematosus (SLE) patients. Biochem Biophys Res Commun 128: 803-808 Quilley J, McGiff JC (1986) Influence of insulin on urinary eicosanoid excretion in rats with experi¬mental diabetes mellitus. J. Pharmacol Exp Ther 238: 606–611

    Google Scholar 

  • Ramanadham S, Lyness WH, Tenner TE (1983) Alterations in aortic and tail artery reactivity after streptozotocin treatment. Can J Physiol Pharmacol 62: 418–423

    Article  Google Scholar 

  • Robertson RP (1986) Arachidonic acid metabolite regulation of insulin secretion. Diabetes Metab Rev 2: 261–296

    Article  PubMed  CAS  Google Scholar 

  • Rosen P, Hohlfeld C (1984) Prostaglandins and diabetes. Ann Clin Res 16: 300–313

    PubMed  CAS  Google Scholar 

  • Saroyan RM, Kerstein MD, Kadowitz PJ, Hyman AL, McNamara DB (1984) Prostacyclin synthetase activity in diabetic human venous tissue. Surgery 96: 179–183

    PubMed  CAS  Google Scholar 

  • Sensaki S, Okuma M, Uchino H (1985) Decreased plasma prostacyclin-regenerating activities in diabetics. Prostaglandins Leukotrienes Med 20: 197–207

    Article  CAS  Google Scholar 

  • Setty BN, Stuart MJ (1986) 15-Hydroxy-5,8,11,13-eicosatetraenoic acid inhibits human vascular cyclooxygenase. Potential role in diabetic vascular disease. J Clin Invest 77: 202–211

    Google Scholar 

  • Shakir KM, Reed HL, O’Brian JT (1986) Decreased phospholipase A2 activity in plasma and liver in uncontrolled diabetes mellitus. A defect in the early steps of prostaglandin synthesis? Diabetes 35: 403–410

    Article  PubMed  CAS  Google Scholar 

  • Silberbauer K, Schernthaner G, Sinzinger H, Pitza-Katzer H, Winter M (1979) Decreased vascular prostacyclin in juvenile-onset diabetes. New Engl J Med 300: 366–367

    PubMed  CAS  Google Scholar 

  • Wakabayashi I, Hatake K, Kimura N, Kakishita E, Nagai K (1987) Modulation of vascular tonus by the endothelium in experimental diabetes. Life Sci 40: 643–648

    Article  PubMed  CAS  Google Scholar 

  • Wiles PG, Johnson M (1985) Plasma prostacyclin-stimulating activity in diabetes mellitus. Horm Metab Res 17: 610–611

    Article  PubMed  CAS  Google Scholar 

  • Wilson TW, Tan LK (1985) Low plasma renin activity in diabetes. Relation to urine prostaglandin excretion. Diabetes 34: 145–150

    Article  PubMed  CAS  Google Scholar 

  • Working Group on Hypertension in Diabetes (1987) Statement on hypertension in diabetes mellitus. Arch Intern Med 147: 830–842

    Article  Google Scholar 

  • Zatz R, Brenner BM (1986) Pathogenesis of diabetic microangiopathy. The hemodynamic view. Am J Med 80: 443–453

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. K. Schrör
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Diabetes-Forschungsinstitut an der Universität Düsseldorf, Auf’m Hennekamp 65, D-4000, Düsseldorf, Federal Republic of Germany

    F. A. Gries

  2. Medizinische Universitäts-Poliklinik, Inselspital, Freiburgstraße 3, CH-3010, Bern, Switzerland

    P. Weidmann

Rights and permissions

Reprints and permissions

Copyright information

© 1988 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Schrör, K. (1988). Eicosanoids and Diabetic Hypertension. In: Gries, F.A., Weidmann, P. (eds) Diabetes and Hypertension. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-73232-4_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-73232-4_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-18623-6

  • Online ISBN: 978-3-642-73232-4

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation